Table 4. Objective response rates post treatment at 3 months.
Response | Target lesion | Overall | |||
---|---|---|---|---|---|
RECIST | PERCIST | RECIST | PERCIST | ||
All (n=8) | |||||
CR | 0 | 1 | 0 | 1 | |
PR | 0 | 4 | 0 | 3 | |
SD | 8 | 2 | 5 | 1 | |
PD | 0 | 1 | 3 | 3 | |
PC (n=3) | |||||
CR | 0 | 0 | 0 | 0 | |
PR | 0 | 1 | 0 | 0 | |
SD | 3 | 1 | 0 | 0 | |
PD | 0 | 1 | 3 | 3 | |
ICC (n=5) | |||||
CR | 0 | 1 | 0 | 1 | |
PR | 0 | 3 | 0 | 3 | |
SD | 5 | 1 | 5 | 1 | |
PD | 0 | 0 | 0 | 0 |
PC, pancreatic cancer; ICC, intrahepatic cholangiocarcinoma; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.